Virbagen canis

Recall | Veterinary Medicines | 06/12/2016

The marketing authorization holder has informed its supplied customers in a letter dated November 30, 2016, that stability tests have revealed a reduced rabies antigen content after 15 months of storage. Therefore, the above mentioned batch of this vaccine is recalled.

Name of the medicinal product Virbagen canis SHAPPi/LT, Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension für Hunde
Marketing authorisation number(s) 8-20138
Marketing authorisation holder Virbac SA

Durchführung Rückruf:
Virbac Österreich GmbH
Batch number(s) 5GF7
Classification of the recall2
BASG reference number INS - 640.001 - 1915

Further inquiry note